Visual Analog Scale–Guided Multimodal Pain Plan After Posterior Rib Remodeling
Official title: Prospective Feasibility, Analgesic Effectiveness, and Safety Study of a Visual Analog Scale-Guided Multimodal Pain Algorithm After Posterior Rib Remodeling With Osteosynthesis
Run by Research Inc · NCT07805928 · Data updated 2026-11-12
This study tests a pain management plan guided by a 0–10 pain score to see if it keeps postoperative pain low after posterior rib remodeling with osteosynthesis.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 55 Years |
| Sex | All |
| Enrollment | 160 (estimated) |
| Sponsor | Research Inc Industry-sponsored |
| Locations | 1 site (Bogotá) |
| Status | Recruiting |
| Started | January 1, 2024 |
| Main results expected | December 12, 2025 |
| Study ends | December 1, 2026 |
| Registry record updated | September 8, 2026 |
| Trial ID | NCT07805928 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–55 undergoing posterior aesthetic rib remodeling with osteosynthesis using the RIBOSS technique, who can reliably report pain scores and complete 5 days of monitoring.
✕Probably not a fit
Patients who do not experience adequate pain control with the predefined algorithm or who have contraindications to the planned analgesic components may see limited benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, single-group study evaluating a pain algorithm guided by a visual analog scale in the first five postoperative days after posterior rib remodeling with osteosynthesis. Pain is measured at multiple time points and treatment is adjusted based on predefined pain tiers and safety rules. The primary outcome is the proportion of pain assessments with scores of 3 or lower, with additional data on protocol adherence, rescue therapy, medication exposure, and adverse events. The approach includes a base nonopioid regimen for mild pain, augmented multimodal strategies for moderate pain, and full multimodal infusion with regional blocks for severe pain. The study also uses an ultrasound-guided regional block as part of the analgesia pathway and collects detailed safety and tolerability information.
Why it matters
Potential benefit: If successful, the algorithm could improve pain control and reduce unnecessary opioid use after chest wall surgery.
How similar studies have gone: Prior studies in multimodal analgesia and pain-guided pathways suggest potential benefits, but this specific VAS-guided protocol after RIBOSS is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 to 55 years. * Scheduled for posterior aesthetic rib remodeling with osteosynthesis using the standardized RIBOSS technique. * Ability to understand and use a 0-to-10 visual analog or numeric pain scale. * Availability for scheduled pain assessments through postoperative hour 120. * Written informed consent. Exclusion Criteria: * Chronic opioid use or opioid use disorder requiring an individualized perioperative plan. * Contraindication to the base nonsteroidal anti-inflammatory drug or acetaminophen regimen and inability to use the predefined alternative pathway. * Contraindication to ketamine, lidocaine, dexmedetomidine, or the planned regional block when those components may be required. * Severe hepatic, renal, cardiac, neurologic, or psychiatric condition judged to make the algorithm unsafe. * Pregnancy or breastfeeding. * Inability to provide reliable pain scores or complete five-day monitoring.
Where it's running
-
Clinica INO
Bogotá, Colombia Recruiting
Study contacts
- Principal investigator: Hugo Aguilar, MD, plastic surgery
- Study coordinator: Hugo Aguilar, MD, Plastic surgeon
- Email: havplasticacademy@gmail.com
- Phone: +57 301 6918526
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
CYT-1010 in healthy volunteers and after third molar extraction
This trial tests CYT-1010, at single rising doses, for safety and tolerability in healthy adults and in people experiencing pain after removing wisdom teeth.
-
Pharmacogenetics of Tramadol Pain Control in Postoperative Care
This study tests whether CYP2D6 genetic differences affect how well tramadol works and its side effects in people recovering from surgery who all receive the same tramadol pump.
-
TENS for acute pain after VATS surgery
A randomized, sham-controlled test will see if Transcutaneous Electrical Nerve Stimulation helps with acute pain after VATS surgery in adults and older teens.
-
DIPB vs SIFIB for pain control after total hip replacement
This will test whether the Deep Iliacus Plane Block (DIPB) or the Suprainguinal Fascia Iliaca Block (SIFIB) gives better pain relief and less leg weakness for adults having elective total hip replacement.
-
Buprenorphine via PCA vs oxycodone for pain after VATS
This trial tests whether intravenous buprenorphine given through a patient-controlled pump provides better and safer pain relief than intravenous oxycodone after video-assisted thoracic surgery in adults.
-
Continuous versus single adductor canal nerve block for outpatient total knee replacement
This test checks whether adding a 5-day continuous adductor canal nerve block to the usual single injection lowers pain and opioid use after outpatient total knee replacement.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.